Intention to Launch an Offer for Subscription

RNS Number : 7575H
Baronsmead Second Venture Trust PLC
05 August 2021
 

Baronsmead Second Venture Trust plc

 

Announcement of Intention to Launch an Offer for Subscription

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

The Directors of Baronsmead Second Venture Trust plc ("the Company") are pleased to announce that the Company intends to launch a new offer for subscription ("the Offer") during the 2021/22 tax year.

 

Full details of the Offer will be contained in a prospectus that is expected to be published in November 2021. A further announcement will be made when the prospectus is available.

 

For further information, please contact:

 

Baronsmead VCT Investor Relations

Telephone - 020 7382 0999

baronsmeadvcts@greshamhouse.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBUGDIBGGDGBU
UK 100

Latest directors dealings